Medicomp Systems, a provider of clinical data solutions, announced on Monday that its customer, Institut Jantung Negara (IJN), the National Heart Institute of Malaysia, has been granted Stage 7 validation by the Healthcare Information and Management Systems Society (HIMSS) Electronic Medical Record Adoption Model (EMRAM).
This is the highest level of digital health maturity recognised by HIMSS. IJN is the first hospital in Malaysia to achieve this milestone.
EMRAM Stage 7 requires hospitals to demonstrate fully paperless operations, robust data analytics capabilities, and the use of clinical data to measurably improve patient outcomes.
IJN, a 433-bed quaternary hospital and the largest integrated cardiovascular and thoracic care centre in Asia, partnered with Medicomp and its regional implementation partner APUK Co Ltd to deploy Quippe, Medicomp's evidence-based clinical documentation and decision support platform. Medicomp says that the implementation drove a rapid digital transformation, with IJN achieving 98% adoption of electronic clinical documentation. IJN had previously become the first hospital in Malaysia to achieve EMRAM Stage 6.
Realheart secures European patent for artificial heart technology
Cumberland Pharmaceuticals secures FDA Fast Track status for DMD heart‑disease therapy ifetroban
Kestra partners with Biobeat to add cuffless blood pressure monitoring to wearable defibrillator
Organon signs commercialisation agreement for Nilemdo across six European markets
Antin to acquire clinical trial equipment provider Emsere
GSK wins European Commission approval for Shingrix prefilled syringe